Skip to main content
. 2023 Sep 4;11(9):1452. doi: 10.3390/vaccines11091452

Figure 2.

Figure 2

Schematic representation of viral-vector vaccine components. (A) Schematic representation of general viral-vector vaccine components. In a viral capsule usually from alternate virus (green), a recombinant DNA is incorporated which contains part of a virus genetic material (inactive and/or harmful) (blue) and the target Plasmodium gene. (B) Schematic representation of two prominent viral-vector-vaccine approaches against malaria in humans.